C12Q 2525/125
Incorporating agents resulting in resistance to degradation
Official title: incorporating agents resulting in resistance to degradation
C12Q2525/125 (Incorporating agents resulting in resistance to degradation) appears on 29 US grants and 36 published applications in this corpus.
Search patents in C12Q- Granted patents
- 29
- Published applications
- 36
- Assignees
- 12
- Inventors
- 38
- Latest grant
- 9 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 3 | 1 |
| 2002 | 1 | 4 |
| 2003 | 0 | 2 |
| 2004 | 1 | 2 |
| 2005 | 0 | 2 |
| 2006 | 2 | 1 |
| 2007 | 0 | 2 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 2 |
| 2013 | 0 | 0 |
| 2014 | 1 | 2 |
| 2015 | 0 | 0 |
| 2016 | 2 | 0 |
| 2017 | 1 | 2 |
| 2018 | 1 | 5 |
| 2019 | 3 | 2 |
| 2020 | 1 | 1 |
| 2021 | 1 | 2 |
| 2022 | 1 | 3 |
| 2023 | 0 | 0 |
| 2024 | 2 | 1 |
| 2025 | 3 | 1 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for detecting or quantifying hepatitis C virus9 Dec 2025US 12,492,437 B2Gen-Probe Incorporated
- Single nucleotide detection method and associated probes19 Aug 2025US 12,391,987 B2Lightcast Discovery Ltd
- Target enrichment via enzymatic digestion in next generation sequencing14 Jan 2025US 12,195,791 B2Saint Louis University
- Chemically-enhanced primer compositions, methods and kits11 Jun 2024US 12,006,536 B2Life Technologies Corporation
- Single nucleotide detection method and associated probes5 Mar 2024US 11,920,192 B2Lightcast Discovery Ltd
- Chemical capping for template switching9 Jul 2026US 2026/0193699 A1New England Biolabs, Inc.
- Chemically-enhanced primer compositions, methods and kits16 Jan 2025US 2025/0019756 A1Life Technologies Corporation
- Single nucleotide detection method and associated probes15 Aug 2024US 2024/0271200 A1Lightcast Discovery Ltd
- Compositions and Methods for Detecting or Quantifying Hepatitis C Virus8 Dec 2022US 2022/0389525 A1Gen-Probe Incorporated
- Chemical Capping for Template Switching23 Jun 2022US 2022/0195424 A1New England Biolabs, Inc.
Most cited
By later US patents
- PNA-DNA-PNA chimeric macromolecules416US 5,700,922 AIsis Pharmaceuticals, Inc. · 1997
- Gapped oligonucleotides224US 7,015,315 B1Isis Pharmaceuticals, Inc. · 2006
- Sugar modified oligonucleotides86US 6,399,754 B1Isis Pharmaceuticals, Inc. · 2002
- Gapped 2′ modified oligonucleotides83US 6,326,199 B1Isis Pharmaceuticals, Inc. · 2001
- Gapped 2' modified oligonucleotides74US 5,955,589 AIsis Pharmaceuticals, Inc. · 1999